Chair, Department of Health Services Research
Professor, Department of Breast Medical Oncology
University of Texas MD Anderson Cancer Center
Male Breast Cancer (BC) is a rare disease accounting for less than 1% of all BC. Knowledge about male BC is scarce, and treatment and management is based on female BC. To better characterize this disease and ultimately develop specific treatments and improve outcomes for men with BC, the Male Breast Cancer International Program was created. Dr. Giordano is part of a team of BCRF grantees participating in this worldwide effort coordinated by the European Organization for the Research and Treatment of Cancer (EORTC), with the help of the Translational Breast Cancer Research Consortium (TBCRC), and run under the network of the Breast International Group (BIG) and the North American Breast Cancer Groups (NABCG). This Program has three parts. Part One is analyzing over 1600 male BC cases treated in the last 20 years to better understand the biology of the disease. This is the largest series of male BC cases ever studied and early results will be presented at the San Antonio Breast Cancer Symposium in 2014. Part Two of the study is focused on creating a registry of all male breast cancer patients treated within the EORTC/TBCRC/BIG/NABCG global network and includes collection of biological material that can be used for future studies. Part Three is a prospective clinical trial that will evaluate a new drug to treat male breast cancer. This program, which includes 23 centers in 9 countries, can exist only due to the continuous and crucial support from BCRF and will lead to the development of better treatment strategies for male breast cancer.
Sharon Giordano is a Professor with tenure at The University of Texas MD Anderson Cancer Center in the Department of Breast Medical Oncology, Chair of the Department of Health Services Research, and Ad Interim Chair of Health Disparities Research.
Dr. Giordano received her undergraduate degree from Yale University and graduated Summa Cum Laude and With Distinction in Biology. She received her MD degree from The Johns Hopkins School of Medicine in 1996. She is a board certified Medical Oncologist. In 2004, Dr. Giordano received a Master of Public Health degree in Disease Control from The University of Texas School of Public Health.
Dr. Giordano’s research interests include breast cancer outcomes research, late effects of treatment, and male breast cancer. She is currently funded through CPRIT, Susan Komen for the Cure, and AHRQ.
Dr. Giordano has received awards including the Faculty Educator of the Month (2009), the Distinguished Alumnus Award (2010), Mentor of the Year Award (2011), Teaching Department of the Year (2011, 2013), and Faculty Scholar Award (2012). Dr. Giordano is the past Track Leader for the ASCO Health Services Program Committee, past member of the ASCO Education Committee, and is a current member and chair of the ASCO Clinical Practice Guidelines Committee. She also serves on the National Comprehensive Cancer Network Breast Cancer Guidelines Committee.